Clinical Trial: Tirzepatide Combined with Standard Therapy for Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD) in Patients with Obesity/Overweight or Type 2 Diabetes: An Exploratory Randomized Controlled Trial (China)

China, Oct. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Tirzepatide Combined with Standard Therapy for Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD) in Patients with Obesity/Overweight or Type 2 Diabetes: An Exploratory Randomized Controlled Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135189

Registration Time: 2026/10/26

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Army Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347339

Published by HT Digital Content Services with permission from Health Daily Digest....